LIPO Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own LIPO shares is 5, representing 0.88% of the company's common stock.

N/A, in the last quarter, reduced its stake in LIPO by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the LIPO shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned LIPO shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, N/A increased its stake in LIPO by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of LIPO to its portfolio, raising its holding to - shares of worth -. N/A also increased its LIPO shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in LIPO is Kaufman Jonathan H , See remarks below. at the company. Additionally, LIPO stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 29.37% percent of Lipella Pharmaceuticals Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which LIPO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Lipella Pharmaceuticals Inc. insiders have bought stock, totalling 0 shares

Around 0 Lipella Pharmaceuticals Inc. shares are held by insiders, which represents about 29.37% of LIPO stock.

LIPO See remarks below., Kaufman Jonathan H holds the largest portfolio of the company's shares. LIPO shares owned by Kaufman total nearly 898.85 thousand.

N/A is the largest institutional owner in LIPO which holds - shares worth - or N/A of the total LIPO shares outstanding followed by N/A with ownership of - shares representing N/A of the LIPO ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the LIPO is concerned, it is a stock which is not optionable.

Number of LIPO shares short is 2.27K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 1.21M shares of LIPO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, LIPO has 650.78K shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for LIPO is 0.01.